Daijun Wang

12# Wu Lu Mu Qi Road
Shanghai, 200040, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Establishment and transcriptomic characteristics of radio-resistant meningioma cell lines.

Establishment and transcriptomic characteristics of radio-resistant meningioma cell lines.

Journal: Journal of neuro-oncology

Published: January 16, 2025

Association of frequent NF2 mutations with spinal location predominance and worse outcomes in psammomatous meningiomas.

Association of frequent NF2 mutations with spinal location predominance and worse outcomes in psammomatous meningiomas.

Journal: Journal of neurosurgery

Published: October 27, 2023

The development of a combined clinico-radiomics model for predicting post-operative recurrence in atypical meningiomas: a multicenter study.

The development of a combined clinico-radiomics model for predicting post-operative recurrence in atypical meningiomas: a multicenter study.

Journal: Journal of neuro-oncology

Published: October 27, 2023

Identification of the Key Immune Cells and Genes for the Diagnostics and Therapeutics of Meningioma.

Identification of the Key Immune Cells and Genes for the Diagnostics and Therapeutics of Meningioma.

Journal: World neurosurgery

Published: May 13, 2023

Loss of H3K27me3 expression enriches in recurrent grade 1&2 meningiomas and maintains as a biomarker stratifying progression risk.

Loss of H3K27me3 expression enriches in recurrent grade 1&2 meningiomas and maintains as a biomarker stratifying progression risk.

Journal: Journal of neuro-oncology

Published: September 24, 2022

Progesterone receptor expression and prediction of benefits of adjuvant radiotherapy in de novo atypical meningiomas after gross-total resection.

Progesterone receptor expression and prediction of benefits of adjuvant radiotherapy in de novo atypical meningiomas after gross-total resection.

Journal: Journal of neurosurgery

Published: June 28, 2022

Favorable Long-Term Outcomes of Chordoid Meningioma Compared With the Other WHO Grade 2 Meningioma Subtypes.

Favorable Long-Term Outcomes of Chordoid Meningioma Compared With the Other WHO Grade 2 Meningioma Subtypes.

Journal: Neurosurgery

Published: June 14, 2022

Distinct clinical outcome of microcystic meningioma as a WHO grade 1 meningioma subtype.

Distinct clinical outcome of microcystic meningioma as a WHO grade 1 meningioma subtype.

Journal: Journal of neuro-oncology

Published: April 28, 2022

Application of MRI-Based Radiomics in Preoperative Prediction of NF2 Alteration in Intracranial Meningiomas.

Application of MRI-Based Radiomics in Preoperative Prediction of NF2 Alteration in Intracranial Meningiomas.

Journal: Frontiers in oncology

Published: February 19, 2022

CBX7 reprograms metabolic flux to protect against meningioma progression by modulating the USP44/c-MYC/LDHA axis.

CBX7 reprograms metabolic flux to protect against meningioma progression by modulating the USP44/c-MYC/LDHA axis.

Journal: Journal of molecular cell biology

Published: January 11, 2022

LncRNA-IMAT1 Promotes Invasion of Meningiomas by Suppressing KLF4/hsa-miR22-3p/Snai1 Pathway.

LncRNA-IMAT1 Promotes Invasion of Meningiomas by Suppressing KLF4/hsa-miR22-3p/Snai1 Pathway.

Journal: Molecules and cells

Published: September 09, 2021

m6A Regulator Expression Segregates Meningiomas Into Biologically Distinct Subtypes.

m6A Regulator Expression Segregates Meningiomas Into Biologically Distinct Subtypes.

Journal: Frontiers in oncology

Published: August 19, 2021

Showing 1-12 of 29

Last Updated: 09/26/2026